JUNERA™ Lift. Sculpt. Define.
Advanced Subdermal Laser Tissue Remodeling for the Face & Body
What does Junera help with? Laxity, Unwanted Fat Or Both.
Junera is a more refined approach to aesthetic contouring begins beneath the surface.
Junera™ is an advanced, dual-wavelength laser platform designed for minimally invasive tissue remodeling, combining precision energy delivery with treatment versatility to address skin laxity, localized adipose tissue, and facial and body contouring concerns.
A more refined approach to aesthetic contouring begins beneath the surface.
Junera™ is an advanced, dual-wavelength laser platform designed for minimally invasive tissue remodeling, combining precision energy delivery with treatment versatility to address skin laxity, localized adipose tissue, and facial and body contouring concerns.
Powered by 980 nm and 1470 nm wavelengths, Junera brings three distinct treatment modes together in one physician-controlled platform: EraLift™, EraSculpt™, and EraDefine™.
The objective is a more individualized approach to aesthetic treatment—one designed around the tissue being targeted, the anatomical area being treated, and the patient’s desired outcome.
From facial definition and skin tightening to targeted body sculpting, Junera bridges the space between surface-level aesthetic treatments and more invasive surgical procedures.
One platform. Two wavelengths. Three treatment pathways. A more precise approach to tissue remodeling.
EXPLORE JUNERA TECHNOLOGY
THE NEXT DIMENSION OF AESTHETIC PRECISION
Address Skin Laxity, Localized Fat, or Both.
Aesthetic concerns rarely exist in isolation.

Skin laxity may affect facial definition. Localized fat may soften the contours of the jawline or body. In other cases, both tissue characteristics contribute to the appearance a patient wants to improve.Junera is designed to address these different treatment objectives through a dual-wavelength platform that supports distinct energy-delivery strategies.
For skin tightening: EraLift™ uses 1470 nm laser energy to target intracellular water within the dermis, supporting thermal stimulation and collagen remodeling.
For precision fat reduction: EraSculpt™ uses 980 nm laser energy, which is absorbed by adipose tissue and hemoglobin, to support targeted thermal lipolysis.
For combined contour refinement: EraDefine™ combines 980 nm and 1470 nm wavelengths to address fat reduction and skin tightening within the same treatment approach.
The result is a versatile treatment platform designed to support individualized tissue remodeling across selected facial and body areas.
Treatment selection, expected outcomes, and candidacy depend on individual anatomy, clinical evaluation, and the specific procedure performed.
THE JUNERA™ PLATFORM
Precision Engineered for the Modern Aesthetic Practice
Junera integrates dual-wavelength laser technology, an intuitive touchscreen interface, and two delivery systems into a compact, mobile platform.

Designed around physician-controlled treatment delivery, the system offers dedicated Face and Body modes to support different anatomical applications.
Two wavelengths.
980 nm + 1470 nm
Two delivery systems.
Bare optical fiber for facial applications and a Contour rigid cannula for body applications, as described in the platform specifications.
3 treatment modes.
EraLift™, EraSculpt™, and EraDefine™.
One integrated platform.
A streamlined approach to treatment versatility, precision, and workflow.
Platform Specifications
| Feature | Junera specification |
|---|---|
| Laser wavelengths | 980 nm + 1470 nm |
| Fiber sizes | 400 μm and 600 μm |
| Body delivery system | Contour 18G rigid cannula |
| Treatment modes | Face and Body |
| Treatment pathways | Lift, Sculpt, Define |
| Intended applications | Selected facial and body tissue remodeling |
Junera’s published platform materials describe a single-treatment approach. The appropriate treatment protocol and whether additional treatment is indicated should be determined by the treating physician.
EXPLORE THE JUNERA TECHNOLOGY PLATFORM
THREE MODES, ALL-IN-ONE INTEGRATED PLATFORM.
EraLift™ — 1470 nm
Refine. Tighten. Restore Definition.
When skin laxity is the primary concern, the treatment strategy must focus on the tissue responsible for firmness and structural support.
EraLift™ uses the 1470 nm wavelength to target intracellular water in the dermis. The resulting controlled thermal interaction is intended to stimulate neocollagenesis—the formation of new collagen—and support improvements in skin tightness.
EraLift may be considered for selected facial and anatomical areas where skin laxity and loss of definition are concerns.
Treatment focus:
- Dermal thermal stimulation
- Collagen remodeling
- Skin tightening
- Improved appearance of selected facial contours
- Facial and neck tissue remodeling, where clinically appropriate
The EraLift approach: Target the dermal component of aesthetic aging with precision-focused laser energy.
EraSculpt™ — 980 nm
Target Localized Fat. Refine Body Contours.
When localized adipose tissue is the primary concern, precision becomes essential.
EraSculpt™ uses the 980 nm wavelength, which is selectively absorbed by adipose tissue and hemoglobin, to facilitate targeted thermal lipolysis.
This treatment mode is designed for selected body-contouring applications where localized fat reduction is an objective.
Treatment focus:
- Targeted thermal lipolysis
- Localized adipose tissue reduction
- Body contour refinement
- Treatment of selected anatomical areas
- Physician-directed energy delivery
The EraSculpt approach: Focus the treatment strategy on localized adipose tissue and the contours that matter to the patient.
EraDefine™ — 980 nm + 1470 nm
Sculpt the Contour. Address Skin Laxity.
Some aesthetic concerns involve more than one tissue target.
Reducing localized fat without adequately considering the skin envelope may not achieve the desired contour. Similarly, addressing skin laxity alone may not resolve the appearance created by underlying adipose tissue.
EraDefine™ combines 980 nm and 1470 nm wavelengths to address both tissue targets within an integrated treatment approach.
Treatment focus:
- Localized fat reduction
- Dermal thermal stimulation
- Skin tightening
- Combined facial or body contour refinement
- Individualized treatment planning
The EraDefine approach: Two wavelengths working toward two complementary objectives within a single platform.
COMPREHENSIVE FACIAL & BODY TISSUE REMODELING NOW AT KOVAK COSMETIC CENTER

Precision for the Areas That Define Your Appearance
Junera’s dual-wavelength technology and complementary delivery systems are designed to support selected applications across multiple anatomical regions.
The appropriate mode depends on the underlying tissue characteristics, the treatment area, and the clinical objective.
Periorbital Area — Eyes & Upper Face
The delicate tissues around the eyes can present specific aesthetic challenges involving skin laxity and changes in tissue structure.
Junera’s published clinical materials report favorable improvement findings for selected periorbital applications. Treatment near the eyes requires particular anatomical expertise, careful patient selection, and appropriate safety protocols.
Midface — Cheeks & Nasolabial Folds
Changes in skin quality, tissue support, and facial contour can affect the appearance of the cheeks and nasolabial folds.
Junera may be considered as part of an individualized tissue-remodeling strategy for appropriate candidates, based on the specific concern and anatomical findings.
Jawline & Jowls — Lower-Face Definition
A less-defined jawline may reflect several factors, including skin laxity, localized fat, and changes in underlying facial structure.
Junera’s treatment modes allow the physician to select a strategy based on whether skin tightening, localized fat reduction, or a combination of objectives is appropriate.
Neck & Submental Area — Refined Contours
The neck and area beneath the chin can be affected by both skin laxity and localized adipose tissue.
Depending on the patient’s anatomy, EraLift™, EraSculpt™, or EraDefine™ may be considered for selected treatment objectives.
Body Remodeling — Arms, Abdomen & Thighs
Localized fat and skin laxity can contribute to contour concerns across the body.
Junera’s body delivery system is designed to support physician-directed treatment of selected anatomical areas, including the arms, abdomen, and thighs, when clinically appropriate.
Specialty Applications — Acne Scars & Rosacea
Junera’s supplied clinical materials also describe research involving acne scars and rosacea-related applications.
These are specialized indications requiring appropriate clinical assessment. Treatment suitability depends on the specific diagnosis, skin characteristics, evidence supporting the intended use, and the physician’s judgment.
CLINICAL EVIDENCE & MEASURABLE OUTCOMES
A Technology Informed by Published Research
Junera’s supplied materials reference more than 15 peer-reviewed publications and clinical research involving subdermal laser treatment and tissue remodeling.
The cited research includes findings related to dermal density, patient and physician satisfaction, and improvement in selected anatomical applications.
These findings provide a starting point for understanding the clinical evidence associated with the technology. Each result must be interpreted in the context of the individual study, including its methodology, patient population, outcome measures, and follow-up period.
Published Figures Highlighted in Junera’s Materials
15+ peer-reviewed publications
A research base cited in the supplied Junera product materials.
534 participants
Identified in the supplied materials as the largest clinical study, attributed to Reynaud et al., 2009. The precise relationship between this study and the Junera platform should be verified before publication.
48.75% increase in dermal density
Reported in the supplied materials in association with Nilforoushzadeh et al., 2024.
Approximately 90% improvement
A figure reported in the supplied materials for a selected periorbital application, attributed to Nilforoushzadeh et al., 2022.
Approximately 90% patient and physician satisfaction
A figure reported in the supplied materials for selected jawline and lower-face applications, attributed to Nilforoushzadeh et al., 2022.
Approximately 90% acne-scar improvement
A figure reported in the supplied materials in association with Nilforoushzadeh et al., 2023.
Important interpretation: These are study-specific figures supplied in the product materials, not guarantees of treatment outcomes. The original publications should be reviewed to confirm the precise endpoints, sample sizes, statistical methods, and whether the reported findings apply directly to the marketed Junera system and its current treatment protocols.
ONE PLATFORM. A MORE INDIVIDUALIZED TREATMENT STRATEGY.
Why the Dual-Wavelength Approach Matters
Aesthetic tissue remodeling requires an understanding of what is contributing to the concern—not simply where it appears.
Junera’s architecture supports a treatment strategy that distinguishes between three different objectives.
When skin laxity is the priority: EraLift™ focuses on the dermal response.
When localized fat is the priority: EraSculpt™ focuses on targeted thermal lipolysis.
When both concerns contribute to the contour: EraDefine™ combines the two wavelengths.
This approach gives the treating physician a framework for selecting the appropriate treatment mode according to individual anatomy and clinical goals.
Rather than presenting one mode as universally superior, Junera brings multiple treatment pathways together in a single platform.
WHAT TO EXPECT FROM A JUNERA TREATMENT
A Physician-Led Approach to Tissue Remodeling
Every procedure begins with determining whether the treatment is appropriate for the patient’s anatomy, goals, and medical history.
01 — Consultation & Assessment
The physician evaluates skin laxity, localized fat, tissue characteristics, the anatomical area, and the patient’s desired outcome.
02 — Individualized Treatment Planning
The treatment objective determines whether EraLift™, EraSculpt™, or EraDefine™ is the most appropriate option to consider.
03 — Precision Laser Delivery
The physician selects the appropriate delivery system and treatment parameters according to the procedure, anatomical area, and established protocol.
04 — Recovery & Follow-Up
The physician provides procedure-specific aftercare guidance and follow-up recommendations. Recovery and results vary according to the treatment performed and individual patient factors.
Junera’s product materials describe a single-treatment approach. However, a single session should not be interpreted as a guarantee of complete correction or permanent results.
JUNERA™ VS. OTHER AESTHETIC TREATMENT APPROACHES
Understanding Where Subdermal Laser Remodeling Fits
Patients exploring facial rejuvenation and body contouring may encounter a range of treatment categories, from topical skin care and surface-based energy treatments to injectable procedures and surgery.
Junera occupies a distinct category focused on minimally invasive, physician-controlled subdermal laser tissue remodeling.
Its dual-wavelength architecture is designed to address selected tissue targets beneath the skin, rather than relying exclusively on surface-level treatment.
The most appropriate comparison depends on the concern being treated.
| Treatment category | Primary consideration |
|---|---|
| Topical skincare | Surface-level skin care and maintenance |
| Surface-based energy treatments | Selected skin-quality and tightening objectives |
| Subdermal laser remodeling | Targeted tissue interaction beneath the skin |
| Injectable treatments | Indication-specific volume, contour, or cosmetic objectives |
| Surgical procedures | Anatomical correction through an operative approach |
These categories are not interchangeable. They differ in technique, indications, expected outcomes, risks, recovery, and suitability.
Junera should be evaluated as one option within an individualized treatment plan—not as a universal replacement for surgery or other established treatments.
PRECISION UNDER THE SURFACE. DEFINITION BY DESIGN.

Discover Junera™ — Lift. Sculpt. Define.
Aesthetic treatment is most effective when technology and clinical judgment work together.
Junera brings dual-wavelength laser engineering, three distinct treatment modes, and facial and body delivery options into one integrated platform designed for physician-controlled tissue remodeling.
Whether the clinical objective involves skin laxity, localized fat, or both, the starting point remains the same: understand the tissue, define the goal, and select the appropriate treatment strategy.
Junera™. Advanced subdermal laser tissue remodeling.
JUNERA™ FREQUENTLY ASKED QUESTIONS
What is Junera laser treatment?
Junera is a dual-wavelength subdermal laser platform designed for minimally invasive tissue remodeling. It combines 980 nm and 1470 nm wavelengths in a system offering EraLift™, EraSculpt™, and EraDefine™ treatment modes for selected facial and body applications.
What is the difference between EraLift, EraSculpt, and EraDefine?
EraLift™ uses 1470 nm energy to target dermal tissue and support collagen remodeling. EraSculpt™ uses 980 nm energy for targeted thermal lipolysis. EraDefine™ combines both wavelengths to address localized fat and skin laxity within one integrated treatment approach.
Can Junera address both skin laxity and localized fat?
The EraDefine™ mode is specifically designed to combine the two wavelengths for these objectives. Whether this approach is appropriate depends on the patient’s anatomy, treatment area, and clinical assessment.
Which areas can be treated with Junera?
The supplied product materials identify applications involving the periorbital area, midface, jawline, neck, submental area, arms, abdomen, and thighs. Specific indications and treatment suitability should be confirmed with a qualified physician.
Is Junera a non-surgical treatment?
Junera is described as a minimally invasive, subdermal laser treatment platform. Because treatment involves access to tissue beneath the skin, it should not be presented as a completely non-invasive procedure. The exact technique and associated risks should be discussed with the treating physician.
How many Junera treatments are needed?
Junera’s supplied materials identify a single-treatment approach. The actual treatment plan and expected degree of correction depend on the indication, individual anatomy, and clinical response. Additional treatment may or may not be appropriate.
How long do Junera results last?
Longevity depends on the indication, the procedure performed, individual healing and collagen remodeling, and ongoing changes in the skin and underlying tissues. Specific durability claims should be supported by published follow-up data for the relevant treatment.
Is Junera suitable for every skin type?
The supplied product materials list Fitzpatrick skin types I–VI. However, the appropriate settings, indications, precautions, and candidacy for each skin type must be established by the treating physician and supported by the applicable clinical evidence and product labeling.
Is Junera backed by clinical research?
The supplied materials reference more than 15 peer-reviewed publications and several clinical outcome figures. Prospective patients and clinicians should review the underlying studies to understand their methods, populations, endpoints, and relevance to the intended treatment.
Who should perform a Junera treatment?
Junera procedures should be performed by appropriately qualified and trained medical professionals who are authorized to provide the specific procedure in their jurisdiction and who understand the relevant anatomy, laser safety requirements, indications, and potential complications.
Answers for Patients & Practitioners
Junera™ Frequently Asked Questions
Clear, concise information about Junera laser tissue remodeling, its wavelengths, treatment modes, and clinical considerations. Explore the fundamentals to help guide an informed conversation with a qualified aesthetic medical professional.
What is Junera™ laser tissue remodeling?
Junera™ is a subdermal laser tissue remodeling platform designed to support minimally invasive aesthetic treatments involving skin laxity, localized fat, or both. Treatment planning depends on the individual's anatomy, goals, and clinical assessment.
What concerns can Junera™ treatments address?
Depending on the selected treatment mode and clinical indication, Junera may be used to address concerns involving skin laxity, facial contour definition, and localized adipose tissue. Potential treatment areas may include the lower face, jawline, submental region, neck, arms, abdomen, and thighs.
Not every concern or anatomical area is appropriate for every patient. A qualified practitioner should determine suitability.
How do the 980 nm and 1470 nm wavelengths differ?
980 nm: The Junera platform describes this wavelength as targeting tissue components associated with adipose tissue and hemoglobin, supporting applications intended for localized fat reduction.
1470 nm: This wavelength is used for its interaction with water-rich tissue, supporting controlled thermal effects associated with dermal remodeling and skin-tightening objectives.
Tissue response depends on treatment parameters, anatomy, technique, and the specific clinical protocol.
What is the difference between EraLift™, EraSculpt™, and EraDefine™?
EraLift™ — 1470 nm: Focuses on subdermal tissue remodeling with the objective of improving skin tightness and supporting collagen remodeling.
EraSculpt™ — 980 nm: Focuses on applications intended to target localized adipose tissue.
EraDefine™ — combined wavelengths: Combines the two wavelengths in a treatment approach intended to address both localized fat and skin laxity when clinically appropriate.
The treating practitioner determines which mode, if any, is suitable for the individual patient.
Is Junera™ a surgical procedure?
Junera is described as a minimally invasive, subdermal laser procedure. It is not equivalent to a noninvasive surface-only treatment, and it should not be assumed to be risk-free or appropriate for everyone.
Ask your provider about the procedure, anesthesia, expected recovery, potential complications, and whether the treatment is appropriate for your needs.
How many treatment sessions are needed?
The number of sessions depends on the indication, treatment area, degree of laxity or localized fat, individual response, and the practitioner's protocol. A single session may be considered in some treatment plans, but one session should not be presented as a guaranteed outcome for every patient.
When will results appear, and how long can they last?
The timing and durability of results vary. Some changes may become apparent earlier, while tissue remodeling and collagen responses can develop over time. Results depend on individual biology, treatment technique, the area treated, and other factors.
Your practitioner can explain the expected timeline and maintenance considerations based on your treatment plan.
Can Junera™ be used on different skin types?
Skin type alone does not determine candidacy. A provider should evaluate skin characteristics, medical history, the intended treatment area, and the device's applicable instructions for use before recommending a procedure.
Any claim that a device is suitable for all Fitzpatrick skin types should be confirmed against the manufacturer's current documentation and relevant clinical evidence.
What are the potential risks and recovery considerations?
As with other minimally invasive procedures, potential risks may include swelling, bruising, discomfort, burns, infection, changes in skin sensation, contour irregularities, asymmetry, scarring, or unsatisfactory results. The risks depend on the treatment area, technique, patient factors, and clinical setting.
Discuss recovery expectations, aftercare instructions, warning signs, and follow-up appointments with your treating provider.
What should practitioners evaluate before treatment?
Practitioners should assess the patient's goals, anatomy, skin and tissue characteristics, relevant medical history, contraindications, and suitability for the intended treatment. They should also review device-specific training, applicable instructions for use, treatment parameters, infection-control requirements, informed consent, and post-procedure care.
Treatment should be performed only by appropriately qualified professionals within their scope of practice and in accordance with applicable regulations.
Where can I find more information about the Junera™ platform?
Review the platform's technical information and treatment-mode descriptions, and ask the manufacturer or your provider for current documentation, applicable indications, safety information, and supporting clinical references.
Have questions about treatment options or clinical suitability? Speak with a qualified aesthetic medical professional.
Explore Junera™ TechnologyMedical & Clinical Disclaimer
Junera is a medical-aesthetic laser platform. Treatment is minimally invasive and involves potential risks, contraindications, and recovery requirements. The information on this page is educational and is not a substitute for professional medical advice or an individualized consultation. Clinical outcomes vary. Published study findings should be interpreted according to their specific methods and endpoints and should not be understood as guaranteed results. All treatment claims, indications, specifications, and regulatory statements should be verified against current manufacturer documentation, applicable product labeling, and the relevant clinical literature before publication.
Junera Skin Tightening in Chicago: Tighter, Younger-Looking Skin
